Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application save search
CYBER ENVIRO-TECH, INC IS FILING AN APPLICATION TO UPGRADE TO OTCQB MARKETPLACE
Published: 2024-04-02 (Crawled : 15:30) - prnewswire.com
CETI | $0.17 163.05% 22K
|
n/a
|
| O: -3.23%
H: 0.0%
C: -4.25%
otcqb application marketplace
Infinant Health Announces Submission of Orphan Drug Designation Application
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
drug health designation application submission
Next.e.GO N.V. Files Application For Opening Of Insolvency Proceedings
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
EGOX | $0.0385 -1.28% -5.69% 5.2M
|
|
| O: 4.55%
H: 10.03%
C: -13.04%
application
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
AUTL | $4.21 -6.03% -5.91% 2.7M
|
Health Technology
|
| O: -7.83%
H: 3.27%
C: -2.48%
authorization application leukemia therapeutics
Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia
Published: 2024-04-02 (Crawled : 11:00) - biospace.com/
RCKT 4 | $23.63 -0.17% -0.13% 920K
|
Health Technology
|
| O: -1.76%
H: 0.0%
C: -1.91%
anemia authorization treatment pharmaceuticals application
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Published: 2024-04-02 (Crawled : 08:00) - biospace.com/
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: -1.18%
H: 0.34%
C: -0.22%
breast her2 license cancer application negative
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
Published: 2024-04-01 (Crawled : 19:00) - biospace.com/
CNTX | $1.3 -7.8% -2.17% 37K
|
Health Technology
|
| O: 8.7%
H: 3.33%
C: -8.67%
ctim-76 application therapeutics
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
Published: 2024-03-31 (Crawled : 00:00) - prnewswire.com
BIIB | $201.99 4.56% 4.32% 2.7M
|
Health Technology
|
| O: -0.88%
H: 0.0%
C: 0.0%
leqembi fda disease license treatment alzheimer's application submission
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for enfortumab vedotin with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Published: 2024-03-28 (Crawled : 15:00) - prnewswire.com
ALPMY | News | $9.47 -0.21% -1.11% 400K
|
Manufacturing
|
| O: 0.82%
H: 0.0%
C: -2.54%
keytruda license bladder cancer treatment medical application advanced
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
Published: 2024-03-28 (Crawled : 13:30) - globenewswire.com
FBLG | $11.52 3.78% 3.9% 69K
|
|
| O: -1.87%
H: 0.0%
C: -6.24%
patent lupus treatment application technology potential
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
MIST | $1.66 -2.35% -1.8% 49K
|
Health Technology
|
| O: 4.44%
H: 0.0%
C: 0.0%
etripamil drug tachycardia resubmission treatment pharmaceuticals application milestone
Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
Published: 2024-03-27 (Crawled : 13:00) - globenewswire.com
CMND | $1.21 -1.68% 31K
|
n/a
|
| O: 0.0%
H: 1.75%
C: 1.75%
SPRC | $1.21 -1.63% -1.23% 75K
|
Manufacturing
|
| O: -3.23%
H: 0.56%
C: -3.33%
patent depression international application
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
Published: 2024-03-27 (Crawled : 13:00) - globenewswire.com
CMND | $1.21 -1.68% 31K
|
n/a
|
| O: 0.0%
H: 1.75%
C: 1.75%
SPRC | $1.21 -1.63% -1.23% 75K
|
Manufacturing
|
| O: -3.23%
H: 0.56%
C: -3.33%
patent depression international collaboration application
World Sexual Health Supplement Market Trends Analysis Report 2024-2030: Capsules Dominate Formulation Segment, Libido-Boosting Supplements Lead Application Segment, Fertility Segment Poised for Growth
Published: 2024-03-27 (Crawled : 02:00) - prnewswire.com
MEDE | $0.51 0% 500
|
n/a
| Email alert
Add to watchlist
report health world trends application growth market
Locafy Launches Hotfrog Proximity Page Application Built in Collaboration with Yext
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
LCFY | $3.69 -16.14% 1.1K
|
n/a
|
| O: -3.95%
H: 3.9%
C: 2.49%
YEXT | $5.5 -0.72% 0.0% 460K
|
Technology Services
|
| O: 0.0%
H: 1.71%
C: -2.28%
collaboration application
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
Published: 2024-03-25 (Crawled : 12:00) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
fda approval treatment application platform
Regeneron Provides Update on Biologics License Application for Odronextamab
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K
|
Health Technology
|
| O: -1.37%
H: 1.15%
C: 0.74%
license update application
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2024-03-21 (Crawled : 21:00) - biospace.com/
VRTX | $400.76 -1.03% -1.06% 810K
|
Health Technology
|
| O: 0.85%
H: 0.88%
C: 0.02%
vx-407 fda drug disease kidney treatment clearance application
Job Application Tracking in a Cookie-less World
Published: 2024-03-21 (Crawled : 17:00) - veritone.com
VERI | $3.56 -7.05% -7.58% 960K
|
Technology Services
|
| O: 1.01%
H: 1.5%
C: -8.25%
world application
United Health Products Submits Full FDA PMA Application
Published: 2024-03-21 (Crawled : 12:30) - globenewswire.com
UEEC | $0.1926 1.37% 7.9% 190K
|
Manufacturing
|
| O: -4.43%
H: 16.61%
C: 0.26%
fda health application
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.